The Bear Cave #340

Wolfpack Research reported Flotek Industries (FTK) lost a $400M contract, potentially halving its backlog. Fugazi Research criticized Aeva Technologies (AEVA) as a struggling startup. Bristlemoon Research argued Macy's (M) is overvalued. L3Harris (LHX) CEO departed over conduct violations. Ameresco (AMRC) CFO and GC resigned. Viking Therapeutics (VKTX) COO and Merit Medical (MMSI) COO departed. Boston Beer (SAM) CFO is stepping down. Edwin Dorsey predicts long-term trouble for DraftKings (DKNG)

Original reporting
Published Aug 23, 2026, 2:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 23, 2026, 4:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Bear Cave #340 — source image
Decision brief

The 30-second read

$FTKBearishLow
01

Why it matters

Overall sentiment is negative due to multiple executive exits and critical research reports, suggesting short‑bias for affected tickers.

02

Market read

The article provides a collection of negative catalysts for several U.S. stocks, but offers no new primary disclosures.

03

What to watch

Potential hidden operational issues not disclosed in the brief.

Relevance 4/10Novelty 2/10Timing: none

Background

The Bear Cave newsletter aggregates recent activist research, executive departures, and opinion pieces.

Company-level read

Ticker impact

$FTKBearishMedium confidence
Context

Wolfpack Research alleges Flotek Industries failed to disclose the cancellation of a $400M PREPA contract, potentially wiping out over 50% of its backlog.

Expected impact

downside pressure

Evidence & confidence

Backlog loss of >50% is material for a $894M market cap company.

$AEVABearishMedium confidence
Context

Fugazi Research calls Aeva Technologies a "bleeding startup" and highlights $11.9M insider selling after its AI-data-center announcement.

Expected impact

downside risk

Evidence & confidence

Research report and insider sell signal weakness.

$MBearishLow confidence
Context

Bristlemoon Research labels Macy's as an "attractive short" despite recent comparable sales improvement.

Expected impact

potential decline

Evidence & confidence

Research opinion without new fundamentals.

$LHXBearishLow confidence
Context

L3Harris Technologies CEO resigned immediately after board discovered code‑of‑conduct violations.

Expected impact

possible dip

Evidence & confidence

CEO exit is material but impact uncertain.

$AMRCBearishLow confidence
Context

Ameresco CFO and CAO are stepping down within a month, with the General Counsel also resigning.

Expected impact

downside risk

Evidence & confidence

Leadership churn often pressures stock.

$VKTXBearishLow confidence
Context

Viking Therapeutics COO disappeared from the website with no disclosure.

Expected impact

potential decline

Evidence & confidence

Lack of transparency is a red flag.

$SAMNeutralLow confidence
Context

Boston Beer CFO announced his resignation effective September 30, with an interim CFO appointed.

Expected impact

minimal impact

Evidence & confidence

Routine CFO change without immediate financial effect.

$MMSINeutralLow confidence
Context

Merit Medical Systems COO gave notice to resign for good reason, effective March 2027 after his position was eliminated.

Expected impact

minimal impact

Evidence & confidence

Resignation effective years away.

Market effects

Activist reports may increase short‑interest in industrial and tech sectors.

No specific regional effect identified.

Limited to U.S. listed companies mentioned.

Counterpoint

Some investors may view the resignations as opportunities for fresh leadership.

Key entities

  • Wolfpack Research

    Published critical report on Flotek Industries.

  • Fugazi Research

    Published critical report on Aeva Technologies.

Related articles

$LHXMed

Why is L3Harris Technologies stock gaining today?

L3Harris Technologies (LHX) stock rose 1% to $264.50 after Jefferies initiated coverage with a Hold rating and $315 price target, citing uncertainty over leadership changes and the IPO of its Missile Solutions unit. The stock has fallen 25% over six months but has a $42B backlog and raised 2026 revenue guidance to $23-23.5B. Defense peers had no major news.

$LHXHighAI 9/10

Are Wall Street Analysts Predicting L3Harris Technologies Stock Will Climb or Sink?

L3Harris Technologies (LHX) reported Q2 FY2026 revenue of $5.88B, up 8.4%, and EPS of $3.13, up 28.3%. Despite growth, shares fell 2.5% post-earnings. Analysts project 10.7% EPS growth for FY2026. The stock has underperformed the S&P 500 and ITA ETF over the past year. Deutsche Bank lowered its price target to $268, maintaining a 'Hold' rating. The mean price target is $366.78, implying 37.5% upside.

$RTXMedAI 8/10

RTX vs. LHX: Which Aerospace Player Holds Stronger Momentum Right Now?

RTX and L3Harris (LHX) are benefiting from rising defense budgets and demand for advanced military tech. RTX has a diversified portfolio, including commercial aerospace and defense, and recently secured significant contracts. L3Harris focuses on defense electronics and space tech, with recent wins in electronic warfare and undersea systems. RTX's 2026 sales and EPS are expected to grow 8.4% and 14.8%, respectively, while LHX's are projected to rise 8.2% and 9.4%. RTX's stock has outperformed LHX